Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial
View ORCID ProfileSatoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara, View ORCID ProfileHideyuki Okano
doi: https://doi.org/10.1101/2021.12.05.21267266
Satoru Morimoto
1Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Shinichi Takahashi
1Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
3Department of Neurology and Stroke, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan
M.D.Daisuke Ito
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Yugaku Daté
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Kensuke Okada
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Chai Muh Chyi
1Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
4Keio University Global Research Institute, Tokyo, 108-8345, Japan
Ph.D.Ayumi Nishiyama
5Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, 980-8575, Japan
M.D.Naoki Suzuki
5Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, 980-8575, Japan
M.D.Koki Fujimori
1Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
Ph.D.Masaki Takao
6Department of Clinical Laboratory, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-0031, Japan
M.D.Miwa Hirai
7Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan
Yasuaki Kabe
7Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan
Ph.D.Makoto Suematsu
7Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Masahiro Jinzaki
8Department of Radiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Masashi Aoki
5Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, 980-8575, Japan
M.D.Yuto Fujiki
9Keio University Hospital Clinical and Translational Research Center, Tokyo, 160-8582, Japan
Yasunori Sato
10Department of Preventive Medicine and Public Health, Keio University School of Medicine, 160-8582, Japan
Ph.D.Norihiro Suzuki
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Jin Nakahara
2Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.Hideyuki Okano
1Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan
M.D.
Posted December 07, 2021.
Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara, Hideyuki Okano
medRxiv 2021.12.05.21267266; doi: https://doi.org/10.1101/2021.12.05.21267266
Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara, Hideyuki Okano
medRxiv 2021.12.05.21267266; doi: https://doi.org/10.1101/2021.12.05.21267266
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)